HB 1772 (2026)
Allow some ibogaine prescriptions, adopt PA licensure compact
This bill is still active.
Allows New Hampshire to participate in a multistate consortium to conduct clinical trials using ibogaine as an investigational new drug for the treatment of substance use disorder and other conditions.
The House rewrote the bill to instead allow health care providers to prescribe ibogaine "for investigational use only."
The Senate amended the bill to allow health care providers to administer ibogaine "under the framework of an FDA-approved research protocol."
The Senate also added the substance of SB 425 to the bill, adopting the physician associate (PA) licensure compact.
The data you see here is pulled daily from official government databases. The bill summary is created by Citizens Count staff. Learn more about our methodology for summarizing and updating bills. Visit the official New Hampshire government website for a deep-dive on this bill.
